202) The Prostate Cancer in a Black Population (PCBP) Study, |
203) ith, very treatable, node negative breast cancer in California between 1996 and 2000 |
204) n passive tobacco smoke and female breast cancer in China. |
205) used to analyze the incidence of thyroid cancer in Shanghai, China, from 1983 to 20 |
206) of adjuvant treatments of stage III colon cancer in a population-based observational |
207) ADH1C (1-2) increased the risk of breast cancer in drinkers (OR = 1.35; 95% CI = 1. |
208) ribute to the etiology of sporadic breast cancer in non-Hispanic white women aged |
209) ites of TYMS with risk of sporadic breast cancer in non-Hispanic white women aged |
210) AhR agonists as a risk factor for breast cancer in offspring through epigenetic inh |
211) besity, which is a risk factor for breast cancer in postmenopausal women, and in par |
212) High mortality rates of breast cancer in the Middle Eastern countries are |
213) RCA1/BRCA2 mutations to hereditary breast cancer in the Tunisian population has not |
214) be included with gynecomastia and breast cancer in the differential diagnosis of ma |
215) ountry that has the highest rates of skin cancer in the world, little is known about |
216) The primary prevention of skin cancer in young people is an illustration |
217) Cancer is increasingly perceived as a syst |
218) Esophageal cancer is aggressive and has poor prognosi |
219) nd cCRP as tools for screening for occult cancer is improved when evaluated together |
220) And fourth, the incidence of esophageal cancer is in continuous flux among groups. |
221) its role in treating resected pancreatic cancer is less clear. |
222) Ovarian cancer is one of the leading causes for de |
223) Lung cancer is the leading cause of cancer-rela |
224) Breast cancer is the leading cause of deaths in w |
225) to other Middle Eastern countries, breast cancer is the most common cancer among wom |
226) Given that breast cancer is the most prevalent form of cance |
227) Metabolic rewiring in cancer is tightly connected to changes at |
228) Anal cancer is uncommon, with an incidence rate |
229) First, the prevalence of esophageal cancer is unevenly distributed throughout |
230) apeutic agent widely used to treat breast cancer, is poorly understood. |
231) s of cancers and might be associated with cancer risk and disease outcome. |
232) rial DNA (mtDNA) might be associated with cancer risk and disease outcome. |
233) examine the association between childhood cancer risk and distance from the home add |
234) may modulate its gene functions and thus cancer risk and patient survival. |
|